Sopharma AD (SPH.WA)
PLN 12.8
(6.22%)
PLN 12.8
(6.22%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 98.11 Million BGN | 8.9% |
| 2022 | 89.56 Million BGN | 0.02% |
| 2021 | 89.54 Million BGN | 95.52% |
| 2020 | 45.8 Million BGN | -57.23% |
| 2019 | 107.08 Million BGN | 173.58% |
| 2018 | 39.14 Million BGN | -29.9% |
| 2017 | 55.83 Million BGN | 24.22% |
| 2016 | 44.95 Million BGN | 23.36% |
| 2015 | 36.44 Million BGN | -8.95% |
| 2014 | 40.02 Million BGN | -24.25% |
| 2013 | 52.83 Million BGN | 16.2% |
| 2012 | 45.46 Million BGN | -1.21% |
| 2011 | 46.02 Million BGN | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 31.96 Million BGN | 83.36% |
| 2024 Q2 | 17.69 Million BGN | -44.66% |
| 2023 Q4 | 17.43 Million BGN | 6.51% |
| 2023 FY | 97.53 Million BGN | 8.9% |
| 2023 Q3 | 16.36 Million BGN | -48.29% |
| 2023 Q1 | 32.07 Million BGN | 77.35% |
| 2023 Q2 | 31.65 Million BGN | -1.31% |
| 2022 Q2 | 21.99 Million BGN | 0.77% |
| 2022 Q3 | 34.92 Million BGN | 58.79% |
| 2022 Q4 | 18.08 Million BGN | -48.21% |
| 2022 Q1 | 21.82 Million BGN | 162.09% |
| 2022 FY | 89.56 Million BGN | 0.02% |
| 2021 Q3 | 21.29 Million BGN | 52.39% |
| 2021 Q4 | 8.32 Million BGN | -60.89% |
| 2021 FY | 89.54 Million BGN | 95.52% |
| 2021 Q1 | 19.92 Million BGN | 53.47% |
| 2021 Q2 | 13.97 Million BGN | -29.87% |
| 2020 Q2 | 8.93 Million BGN | -48.15% |
| 2020 FY | 45.8 Million BGN | -57.23% |
| 2020 Q4 | 12.98 Million BGN | 113.8% |
| 2020 Q3 | 6.07 Million BGN | -32.05% |
| 2020 Q1 | 17.23 Million BGN | -7.85% |
| 2019 Q2 | 10.61 Million BGN | -39.43% |
| 2019 Q4 | 18.7 Million BGN | 45.46% |
| 2019 FY | 107.08 Million BGN | 173.58% |
| 2019 Q1 | 17.51 Million BGN | 252.21% |
| 2019 Q3 | 12.85 Million BGN | 21.16% |
| 2018 Q2 | 10.35 Million BGN | -38.36% |
| 2018 FY | 39.14 Million BGN | -29.9% |
| 2018 Q1 | 16.79 Million BGN | 36.75% |
| 2018 Q3 | 7.02 Million BGN | -32.15% |
| 2018 Q4 | 4.97 Million BGN | -29.19% |
| 2017 Q1 | 21.46 Million BGN | 64.43% |
| 2017 Q3 | 9.81 Million BGN | -20.07% |
| 2017 Q4 | 12.28 Million BGN | 25.14% |
| 2017 FY | 55.83 Million BGN | 24.22% |
| 2017 Q2 | 12.27 Million BGN | -42.81% |
| 2016 Q2 | 6.63 Million BGN | -57.0% |
| 2016 FY | 44.95 Million BGN | 23.36% |
| 2016 Q1 | 15.43 Million BGN | 127.22% |
| 2016 Q4 | 13.05 Million BGN | 32.93% |
| 2016 Q3 | 9.82 Million BGN | 47.95% |
| 2015 FY | 36.44 Million BGN | -8.95% |
| 2015 Q4 | 6.79 Million BGN | 229.01% |
| 2015 Q3 | 2.06 Million BGN | -79.24% |
| 2015 Q2 | 9.94 Million BGN | -43.6% |
| 2015 Q1 | 17.63 Million BGN | 374.19% |
| 2014 Q4 | 3.71 Million BGN | -26.7% |
| 2014 FY | 40.02 Million BGN | -24.25% |
| 2014 Q1 | 21.02 Million BGN | 116.1% |
| 2014 Q2 | 10.2 Million BGN | -51.44% |
| 2014 Q3 | 5.07 Million BGN | -50.3% |
| 2013 Q3 | 3.37 Million BGN | -81.25% |
| 2013 Q4 | 9.72 Million BGN | 188.24% |
| 2013 FY | 52.83 Million BGN | 16.2% |
| 2013 Q1 | 21.72 Million BGN | 819.12% |
| 2013 Q2 | 18 Million BGN | -17.14% |
| 2012 Q1 | 16.9 Million BGN | 0.0% |
| 2012 FY | 45.46 Million BGN | -1.21% |
| 2012 Q3 | 10.87 Million BGN | -29.0% |
| 2012 Q4 | 2.36 Million BGN | -78.27% |
| 2012 Q2 | 15.31 Million BGN | -9.4% |
| 2011 FY | 46.02 Million BGN | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|